FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 31 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,056,000 | 0.85% |
| Southpoint Capital Advisors LP | 3,997,214 | $19,386,000 | 0.82% |
| 683 Capital Management, LLC | 971,351 | $4,711,000 | 0.43% |
| Avoro Capital Advisors LLC | 1,105,999 | $5,364,000 | 0.23% |
| Eventide Asset Management | 720,000 | $3,492,000 | 0.12% |
| Granahan Investment Management | 410,932 | $1,993,000 | 0.11% |
| Zebra Capital Management LLC | 17,568 | $85,000 | 0.04% |
| Hartford Financial Management Inc. | 12,300 | $60,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 84,750 | $411,000 | 0.01% |
| Wealthspire Advisors, L.P. | 9,500 | $46,000 | 0.00% |